DOI: 10.1038/sj.bmt.1703132. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide

Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide

10.1038/sj.bmt.1703132

Crossref journal-article

Springer Science and Business Media LLC

Bone Marrow Transplantation (297)

Bibliography

Morandi, P., Ruffini, P., Benvenuto, G., La Vecchia, L., Mezzena, G., & Raimondi, R. (2001). Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7âg/m2) cyclophosphamide. Bone Marrow Transplantation, 28(3), 277â282.

Authors 6

P Morandi (first)
PA Ruffini (additional)
GM Benvenuto (additional)
L La Vecchia (additional)
G Mezzena (additional)
R Raimondi (additional)

References 36 Referenced 66

Lee CK, Harman GS, Hohl RJ et al. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment Bone Marrow Transplant 1996 18: 573–577 / Bone Marrow Transplant by CK Lee (1996)
Ayash LJ, Wright JE, Tretyakov O et al. Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response J Clin Oncol 1992 10: 995–1000 (10.1200/JCO.1992.10.6.995) / J Clin Oncol by LJ Ayash (1992)
Braverman AC, Antin JH, Plappert MT et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens J Clin Oncol 1991 9: 1215–1223 (10.1200/JCO.1991.9.7.1215) / J Clin Oncol by AC Braverman (1991)
Gottdiener JS, Appelbaum FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 1981 141: 758–763 (10.1001/archinte.1981.00340060066015) / Arch Intern Med by JS Gottdiener (1981)
Chapelle JP . Cardiac troponin I and troponin T: recent players in the field of myocardial markers Clin Chem Lab Med 1999 37: 11–20 (10.1515/CCLM.1999.002) / Clin Chem Lab Med by JP Chapelle (1999)
Stubbs P . The cardiac troponins: uses in routine clinical practice. Experiences from GUSTO and other clinical trials Eur Heart J 1998 19: (Suppl. N) N59–63 (10.1053/euhj.1998.1043) / Eur Heart J by P Stubbs (1998)
Stromme JH, Johansen O, Brekke M et al. Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I Scand J Clin Lab Invest 1998 58: 693–699 (10.1080/00365519850186139) / Scand J Clin Lab Invest by JH Stromme (1998)
La Vecchia L, Mezzena G, Ometto R et al. Detectable serum troponin I in patients with heart failure of non myocardial ischemic origin Am J Cardiol 1997 80: 482–485 (10.1159/000177381) / Am J Cardiol by L La Vecchia (1997)
Lauer B, Niederau C, Kuhl U et al. Cardiac troponin T in patients with clinically suspected myocarditis J Am Coll Cardiol 1997 30: 1354–1359 (10.1016/S0735-1097(97)00317-3) / J Am Coll Cardiol by B Lauer (1997)
Gianni AM, Siena S, Bregni M et al. Efficacy, toxicity and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more axillary nodes involved – five-year results J Clin Oncol 1997 15: 2312–2321 (10.1200/JCO.1997.15.6.2312) / J Clin Oncol by AM Gianni (1997)
Gianni AM, Bregni M, Siena S et al. Recombinant human granulocyte–macrophage colony stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non Hodgkin's lymphoma J Clin Oncol 1990 8: 768–778 (10.1200/JCO.1990.8.5.768) / J Clin Oncol by AM Gianni (1990)
Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes New Engl J Med 1996 335: 1342–1349 (10.1056/NEJM199610313351802) / New Engl J Med by EM Antman (1996)
Bregni M, Siena S, Di Nicola M et al. Dose–response effect of cyclophosphamide in locally advanced/metastatic breast cancer Bone Marrow Transplant 1998 21: (Suppl. 1) S59 (abstr. 210) (10.1038/sj.bmt.1701035) / Bone Marrow Transplant by M Bregni (1998)
Siena S, Bregni M, Brando B et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte–macrophage colony stimulating factor Blood 1989 74: 1905–1914 (10.1182/blood.V74.6.1905.1905) / Blood by S Siena (1989)
Zujewski J, Nelson A, Abrams J . Much ado about not enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer J Natl Cancer Inst 1998 90: 200–209 (10.1093/jnci/90.3.200) / J Natl Cancer Inst by J Zujewski (1998)
Neymark N, Rosti G, Ferrante P et al. Peripheral blood stem cell transplantation for breast carcinoma in Europe 1998. A joint EBMT and EORTC report Proc Am Soc Clin Oncol 1999 18: 64 (Abstr. 238) / Proc Am Soc Clin Oncol by N Neymark (1999)
Steinherz LJ, Steinherz PG . Cyclophosphamide cardiotoxicity Cancer Bull 1985 37: 231–236 / Cancer Bull by LJ Steinherz (1985)
Klein JL, Maroto Rey P, Dansey RD et al. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer Bone Marrow Transplant 2000 25: 1047–1052 (10.1038/sj.bmt.1702394) / Bone Marrow Transplant by JL Klein (2000)
Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors Bone Marrow Transplant 2000 25: 885–894 (10.1038/sj.bmt.1702234) / Bone Marrow Transplant by BE Brockstein (2000)
Hughes-Davies L, Sacks D, Rescigno J et al. Serum cardiac troponin T levels during treatment of early-stage breast cancer J Clin Oncol 1995 13: 2582–2584 (10.1200/JCO.1995.13.10.2582) / J Clin Oncol by L Hughes-Davies (1995)
Raderer M, Kornek G, Weinlander G et al. Serum troponin T levels in adults undergoing anthracycline therapy J Natl Cancer Inst 1997 89: 171 (10.1093/jnci/89.2.171) / J Natl Cancer Inst by M Raderer (1997)
Lipshultz SE, Rifai N, Sallan SE et al. Predictive value of cardiac troponin T in paediatric patients at risk for myocardial injury Circulation 1997 96: 2641–2648 (10.1161/01.CIR.96.8.2641) / Circulation by SE Lipshultz (1997)
Herman HE, Zhang J, Lipshultz SE et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin J Clin Oncol 1999 17: 2237–2244 (10.1200/JCO.1999.17.7.2237) / J Clin Oncol by HE Herman (1999)
Sparano JA, Wolff AC, Brown D . Troponins for predicting cardiotoxicity from cancer therapy Lancet 2000 356: 1947–1948 (10.1016/S0140-6736(00)03304-3) / Lancet by JA Sparano (2000)
Auner HW, Tinchon C, Quehenberger F et al. Troponins in prediction of cardiotoxic effects Lancet 2001 357: 808 (10.1016/S0140-6736(05)71241-1) / Lancet by HW Auner (2001)
Missov E, Calzolari C, Davy JM et al. Cardiac troponin I in patients with hematologic malignancies Coron Artery Dis 1997 8: 537–541 / Coron Artery Dis by E Missov (1997)
Cardinale D, Sandri MT, Martinoni A et al. Left ventricular disfunction predicted by early troponin I release after high-dose chemotherapy J Am Coll Cardiol 2000 36: 517–522 (10.1016/S0735-1097(00)00748-8) / J Am Coll Cardiol by D Cardinale (2000)
Busse D, Busch WF, Bohnenstengel F et al. Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism J Clin Oncol 1997 15: 1885–1896 (10.1200/JCO.1997.15.5.1885) / J Clin Oncol by D Busse (1997)
Ren S, Kalhorn TF, McDonald GB et al. Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients Clin Pharmacol Ther 1998 64: 289–301 (10.1016/S0009-9236(98)90178-3) / Clin Pharmacol Ther by S Ren (1998)
Chen TL, Kennedy MJ, Anderson LW et al. Non linearpharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Drug Metab Dis 1997 25: 544–551 / Drug Metab Dis by TL Chen (1997)
Slattery JT, Kalhorn MJ, McDonald GB et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients J Clin Oncol 1996 14: 1484–1494 (10.1200/JCO.1996.14.5.1484) / J Clin Oncol by JT Slattery (1996)
Gilbert CJ, Petros WP, Vredenburgh J et al. Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer Cancer Chemother Pharmacol 1998 42: 497–503 (10.1007/s002800050851) / Cancer Chemother Pharmacol by CJ Gilbert (1998)
Huitema AD, Mathot RA, Tibben MM et al. Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy Br J Clin Pharmacol 2001 51: 61–70 (10.1046/j.1365-2125.2001.01301.x) / Br J Clin Pharmacol by AD Huitema (2001)
Huitema AD, Kerbusch T, Tibben MM et al. Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens Cancer Chemother Pharmacol 2000 46: 119–127 (10.1007/s002800000132) / Cancer Chemother Pharmacol by AD Huitema (2000)
Voelcker G, Wagner T, Wientzek C et al. Pharmacokinetics of ‘activated’ cyclophosphamide and therapeutic efficacies Cancer 1984 54: 1179–1186 (10.1002/1097-0142(19840915)54:1+<1179::AID-CNCR2820541315>3.0.CO;2-P) / Cancer by G Voelcker (1984)
Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma New Engl J Med 1997 336: 1290–1297 (10.1056/NEJM199705013361804) / New Engl J Med by AM Gianni (1997)

Dates

Type	When
Created	22 years, 11 months ago (Sept. 17, 2002, 12:37 p.m.)
Deposited	3 years, 5 months ago (March 23, 2022, 6:19 p.m.)
Indexed	1 year, 1 month ago (July 30, 2024, 4:27 a.m.)
Issued	24 years, 1 month ago (Aug. 1, 2001)
Published	24 years, 1 month ago (Aug. 1, 2001)
Published Online	24 years ago (Sept. 4, 2001)
Published Print	24 years, 1 month ago (Aug. 1, 2001)

Funders 0

None

BibTeX

@article{Morandi_2001, title={Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide}, volume={28}, ISSN={1476-5365}, url={http://dx.doi.org/10.1038/sj.bmt.1703132}, DOI={10.1038/sj.bmt.1703132}, number={3}, journal={Bone Marrow Transplantation}, publisher={Springer Science and Business Media LLC}, author={Morandi, P and Ruffini, PA and Benvenuto, GM and La Vecchia, L and Mezzena, G and Raimondi, R}, year={2001}, month=aug, pages={277–282} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        7,
        30
      ]
    ],
    "date-time": "2024-07-30T08:27:48Z",
    "timestamp": 1722328068462
  },
  "reference-count": 36,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2001,
            8,
            1
          ]
        ],
        "date-time": "2001-08-01T00:00:00Z",
        "timestamp": 996624000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.springer.com/tdm"
    },
    {
      "start": {
        "date-parts": [
          [
            2001,
            8,
            1
          ]
        ],
        "date-time": "2001-08-01T00:00:00Z",
        "timestamp": 996624000000
      },
      "content-version": "vor",
      "delay-in-days": 0,
      "URL": "https://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [
      "link.springer.com"
    ],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        8,
        1
      ]
    ]
  },
  "DOI": "10.1038/sj.bmt.1703132",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        9,
        17
      ]
    ],
    "date-time": "2002-09-17T16:37:23Z",
    "timestamp": 1032280643000
  },
  "page": "277-282",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "source": "Crossref",
  "is-referenced-by-count": 66,
  "title": "Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7\u2009g/m2) cyclophosphamide",
  "prefix": "10.1038",
  "volume": "28",
  "author": [
    {
      "given": "P",
      "family": "Morandi",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "PA",
      "family": "Ruffini",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "GM",
      "family": "Benvenuto",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "L",
      "family": "La Vecchia",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "G",
      "family": "Mezzena",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "R",
      "family": "Raimondi",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "published-online": {
    "date-parts": [
      [
        2001,
        9,
        4
      ]
    ]
  },
  "reference": [
    {
      "key": "BF1703132_CR1",
      "first-page": "573",
      "volume": "18",
      "author": "CK Lee",
      "year": "1996",
      "unstructured": "Lee CK, Harman GS, Hohl RJ et al. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment Bone Marrow Transplant 1996 18: 573\u2013577",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "BF1703132_CR2",
      "doi-asserted-by": "publisher",
      "first-page": "995",
      "DOI": "10.1200/JCO.1992.10.6.995",
      "volume": "10",
      "author": "LJ Ayash",
      "year": "1992",
      "unstructured": "Ayash LJ, Wright JE, Tretyakov O et al. Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response J Clin Oncol 1992 10: 995\u20131000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR3",
      "doi-asserted-by": "publisher",
      "first-page": "1215",
      "DOI": "10.1200/JCO.1991.9.7.1215",
      "volume": "9",
      "author": "AC Braverman",
      "year": "1991",
      "unstructured": "Braverman AC, Antin JH, Plappert MT et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens J Clin Oncol 1991 9: 1215\u20131223",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR4",
      "doi-asserted-by": "publisher",
      "first-page": "758",
      "DOI": "10.1001/archinte.1981.00340060066015",
      "volume": "141",
      "author": "JS Gottdiener",
      "year": "1981",
      "unstructured": "Gottdiener JS, Appelbaum FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 1981 141: 758\u2013763",
      "journal-title": "Arch Intern Med"
    },
    {
      "key": "BF1703132_CR5",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "DOI": "10.1515/CCLM.1999.002",
      "volume": "37",
      "author": "JP Chapelle",
      "year": "1999",
      "unstructured": "Chapelle JP . Cardiac troponin I and troponin T: recent players in the field of myocardial markers Clin Chem Lab Med 1999 37: 11\u201320",
      "journal-title": "Clin Chem Lab Med"
    },
    {
      "key": "BF1703132_CR6",
      "doi-asserted-by": "publisher",
      "first-page": "N59",
      "DOI": "10.1053/euhj.1998.1043",
      "volume": "19",
      "author": "P Stubbs",
      "year": "1998",
      "unstructured": "Stubbs P . The cardiac troponins: uses in routine clinical practice. Experiences from GUSTO and other clinical trials Eur Heart J 1998 19: (Suppl. N) N59\u201363",
      "journal-title": "Eur Heart J"
    },
    {
      "key": "BF1703132_CR7",
      "doi-asserted-by": "publisher",
      "first-page": "693",
      "DOI": "10.1080/00365519850186139",
      "volume": "58",
      "author": "JH Stromme",
      "year": "1998",
      "unstructured": "Stromme JH, Johansen O, Brekke M et al. Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I Scand J Clin Lab Invest 1998 58: 693\u2013699",
      "journal-title": "Scand J Clin Lab Invest"
    },
    {
      "key": "BF1703132_CR8",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "DOI": "10.1159/000177381",
      "volume": "80",
      "author": "L La Vecchia",
      "year": "1997",
      "unstructured": "La Vecchia L, Mezzena G, Ometto R et al. Detectable serum troponin I in patients with heart failure of non myocardial ischemic origin Am J Cardiol 1997 80: 482\u2013485",
      "journal-title": "Am J Cardiol"
    },
    {
      "key": "BF1703132_CR9",
      "doi-asserted-by": "publisher",
      "first-page": "1354",
      "DOI": "10.1016/S0735-1097(97)00317-3",
      "volume": "30",
      "author": "B Lauer",
      "year": "1997",
      "unstructured": "Lauer B, Niederau C, Kuhl U et al. Cardiac troponin T in patients with clinically suspected myocarditis J Am Coll Cardiol 1997 30: 1354\u20131359",
      "journal-title": "J Am Coll Cardiol"
    },
    {
      "key": "BF1703132_CR10",
      "doi-asserted-by": "publisher",
      "first-page": "2312",
      "DOI": "10.1200/JCO.1997.15.6.2312",
      "volume": "15",
      "author": "AM Gianni",
      "year": "1997",
      "unstructured": "Gianni AM, Siena S, Bregni M et al. Efficacy, toxicity and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more axillary nodes involved \u2013 five-year results J Clin Oncol 1997 15: 2312\u20132321",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR11",
      "doi-asserted-by": "publisher",
      "first-page": "768",
      "DOI": "10.1200/JCO.1990.8.5.768",
      "volume": "8",
      "author": "AM Gianni",
      "year": "1990",
      "unstructured": "Gianni AM, Bregni M, Siena S et al. Recombinant human granulocyte\u2013macrophage colony stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non Hodgkin's lymphoma J Clin Oncol 1990 8: 768\u2013778",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR12",
      "doi-asserted-by": "publisher",
      "first-page": "1342",
      "DOI": "10.1056/NEJM199610313351802",
      "volume": "335",
      "author": "EM Antman",
      "year": "1996",
      "unstructured": "Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes New Engl J Med 1996 335: 1342\u20131349",
      "journal-title": "New Engl J Med"
    },
    {
      "key": "BF1703132_CR13",
      "doi-asserted-by": "publisher",
      "first-page": "S59",
      "DOI": "10.1038/sj.bmt.1701035",
      "volume": "21",
      "author": "M Bregni",
      "year": "1998",
      "unstructured": "Bregni M, Siena S, Di Nicola M et al. Dose\u2013response effect of cyclophosphamide in locally advanced/metastatic breast cancer Bone Marrow Transplant 1998 21: (Suppl. 1) S59 (abstr. 210)",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "BF1703132_CR14",
      "doi-asserted-by": "crossref",
      "first-page": "1905",
      "DOI": "10.1182/blood.V74.6.1905.1905",
      "volume": "74",
      "author": "S Siena",
      "year": "1989",
      "unstructured": "Siena S, Bregni M, Brando B et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte\u2013macrophage colony stimulating factor Blood 1989 74: 1905\u20131914",
      "journal-title": "Blood"
    },
    {
      "key": "BF1703132_CR15",
      "doi-asserted-by": "publisher",
      "first-page": "200",
      "DOI": "10.1093/jnci/90.3.200",
      "volume": "90",
      "author": "J Zujewski",
      "year": "1998",
      "unstructured": "Zujewski J, Nelson A, Abrams J . Much ado about not enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer J Natl Cancer Inst 1998 90: 200\u2013209",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "BF1703132_CR16",
      "first-page": "64",
      "volume": "18",
      "author": "N Neymark",
      "year": "1999",
      "unstructured": "Neymark N, Rosti G, Ferrante P et al. Peripheral blood stem cell transplantation for breast carcinoma in Europe 1998. A joint EBMT and EORTC report Proc Am Soc Clin Oncol 1999 18: 64 (Abstr. 238)",
      "journal-title": "Proc Am Soc Clin Oncol"
    },
    {
      "key": "BF1703132_CR17",
      "first-page": "231",
      "volume": "37",
      "author": "LJ Steinherz",
      "year": "1985",
      "unstructured": "Steinherz LJ, Steinherz PG . Cyclophosphamide cardiotoxicity Cancer Bull 1985 37: 231\u2013236",
      "journal-title": "Cancer Bull"
    },
    {
      "key": "BF1703132_CR18",
      "doi-asserted-by": "publisher",
      "first-page": "1047",
      "DOI": "10.1038/sj.bmt.1702394",
      "volume": "25",
      "author": "JL Klein",
      "year": "2000",
      "unstructured": "Klein JL, Maroto Rey P, Dansey RD et al. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer Bone Marrow Transplant 2000 25: 1047\u20131052",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "BF1703132_CR19",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "DOI": "10.1038/sj.bmt.1702234",
      "volume": "25",
      "author": "BE Brockstein",
      "year": "2000",
      "unstructured": "Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors Bone Marrow Transplant 2000 25: 885\u2013894",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "BF1703132_CR20",
      "doi-asserted-by": "publisher",
      "first-page": "2582",
      "DOI": "10.1200/JCO.1995.13.10.2582",
      "volume": "13",
      "author": "L Hughes-Davies",
      "year": "1995",
      "unstructured": "Hughes-Davies L, Sacks D, Rescigno J et al. Serum cardiac troponin T levels during treatment of early-stage breast cancer J Clin Oncol 1995 13: 2582\u20132584",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR21",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "DOI": "10.1093/jnci/89.2.171",
      "volume": "89",
      "author": "M Raderer",
      "year": "1997",
      "unstructured": "Raderer M, Kornek G, Weinlander G et al. Serum troponin T levels in adults undergoing anthracycline therapy J Natl Cancer Inst 1997 89: 171",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "BF1703132_CR22",
      "doi-asserted-by": "publisher",
      "first-page": "2641",
      "DOI": "10.1161/01.CIR.96.8.2641",
      "volume": "96",
      "author": "SE Lipshultz",
      "year": "1997",
      "unstructured": "Lipshultz SE, Rifai N, Sallan SE et al. Predictive value of cardiac troponin T in paediatric patients at risk for myocardial injury Circulation 1997 96: 2641\u20132648",
      "journal-title": "Circulation"
    },
    {
      "key": "BF1703132_CR23",
      "doi-asserted-by": "publisher",
      "first-page": "2237",
      "DOI": "10.1200/JCO.1999.17.7.2237",
      "volume": "17",
      "author": "HE Herman",
      "year": "1999",
      "unstructured": "Herman HE, Zhang J, Lipshultz SE et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin J Clin Oncol 1999 17: 2237\u20132244",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR24",
      "doi-asserted-by": "publisher",
      "first-page": "1947",
      "DOI": "10.1016/S0140-6736(00)03304-3",
      "volume": "356",
      "author": "JA Sparano",
      "year": "2000",
      "unstructured": "Sparano JA, Wolff AC, Brown D . Troponins for predicting cardiotoxicity from cancer therapy Lancet 2000 356: 1947\u20131948",
      "journal-title": "Lancet"
    },
    {
      "key": "BF1703132_CR25",
      "doi-asserted-by": "publisher",
      "first-page": "808",
      "DOI": "10.1016/S0140-6736(05)71241-1",
      "volume": "357",
      "author": "HW Auner",
      "year": "2001",
      "unstructured": "Auner HW, Tinchon C, Quehenberger F et al. Troponins in prediction of cardiotoxic effects Lancet 2001 357: 808",
      "journal-title": "Lancet"
    },
    {
      "key": "BF1703132_CR26",
      "first-page": "537",
      "volume": "8",
      "author": "E Missov",
      "year": "1997",
      "unstructured": "Missov E, Calzolari C, Davy JM et al. Cardiac troponin I in patients with hematologic malignancies Coron Artery Dis 1997 8: 537\u2013541",
      "journal-title": "Coron Artery Dis"
    },
    {
      "key": "BF1703132_CR27",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "DOI": "10.1016/S0735-1097(00)00748-8",
      "volume": "36",
      "author": "D Cardinale",
      "year": "2000",
      "unstructured": "Cardinale D, Sandri MT, Martinoni A et al. Left ventricular disfunction predicted by early troponin I release after high-dose chemotherapy J Am Coll Cardiol 2000 36: 517\u2013522",
      "journal-title": "J Am Coll Cardiol"
    },
    {
      "key": "BF1703132_CR28",
      "doi-asserted-by": "publisher",
      "first-page": "1885",
      "DOI": "10.1200/JCO.1997.15.5.1885",
      "volume": "15",
      "author": "D Busse",
      "year": "1997",
      "unstructured": "Busse D, Busch WF, Bohnenstengel F et al. Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism J Clin Oncol 1997 15: 1885\u20131896",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR29",
      "doi-asserted-by": "publisher",
      "first-page": "289",
      "DOI": "10.1016/S0009-9236(98)90178-3",
      "volume": "64",
      "author": "S Ren",
      "year": "1998",
      "unstructured": "Ren S, Kalhorn TF, McDonald GB et al. Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients Clin Pharmacol Ther 1998 64: 289\u2013301",
      "journal-title": "Clin Pharmacol Ther"
    },
    {
      "key": "BF1703132_CR30",
      "first-page": "544",
      "volume": "25",
      "author": "TL Chen",
      "year": "1997",
      "unstructured": "Chen TL, Kennedy MJ, Anderson LW et al. Non linearpharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Drug Metab Dis 1997 25: 544\u2013551",
      "journal-title": "Drug Metab Dis"
    },
    {
      "key": "BF1703132_CR31",
      "doi-asserted-by": "publisher",
      "first-page": "1484",
      "DOI": "10.1200/JCO.1996.14.5.1484",
      "volume": "14",
      "author": "JT Slattery",
      "year": "1996",
      "unstructured": "Slattery JT, Kalhorn MJ, McDonald GB et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients J Clin Oncol 1996 14: 1484\u20131494",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "BF1703132_CR32",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "DOI": "10.1007/s002800050851",
      "volume": "42",
      "author": "CJ Gilbert",
      "year": "1998",
      "unstructured": "Gilbert CJ, Petros WP, Vredenburgh J et al. Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer Cancer Chemother Pharmacol 1998 42: 497\u2013503",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "BF1703132_CR33",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "DOI": "10.1046/j.1365-2125.2001.01301.x",
      "volume": "51",
      "author": "AD Huitema",
      "year": "2001",
      "unstructured": "Huitema AD, Mathot RA, Tibben MM et al. Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy Br J Clin Pharmacol 2001 51: 61\u201370",
      "journal-title": "Br J Clin Pharmacol"
    },
    {
      "key": "BF1703132_CR34",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "DOI": "10.1007/s002800000132",
      "volume": "46",
      "author": "AD Huitema",
      "year": "2000",
      "unstructured": "Huitema AD, Kerbusch T, Tibben MM et al. Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens Cancer Chemother Pharmacol 2000 46: 119\u2013127",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "BF1703132_CR35",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "DOI": "10.1002/1097-0142(19840915)54:1+<1179::AID-CNCR2820541315>3.0.CO;2-P",
      "volume": "54",
      "author": "G Voelcker",
      "year": "1984",
      "unstructured": "Voelcker G, Wagner T, Wientzek C et al. Pharmacokinetics of \u2018activated\u2019 cyclophosphamide and therapeutic efficacies Cancer 1984 54: 1179\u20131186",
      "journal-title": "Cancer"
    },
    {
      "key": "BF1703132_CR36",
      "doi-asserted-by": "publisher",
      "first-page": "1290",
      "DOI": "10.1056/NEJM199705013361804",
      "volume": "336",
      "author": "AM Gianni",
      "year": "1997",
      "unstructured": "Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma New Engl J Med 1997 336: 1290\u20131297",
      "journal-title": "New Engl J Med"
    }
  ],
  "container-title": "Bone Marrow Transplantation",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://www.nature.com/articles/1703132",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/1703132.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/1703132.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2022,
        3,
        23
      ]
    ],
    "date-time": "2022-03-23T22:19:56Z",
    "timestamp": 1648073996000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/1703132"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        8,
        1
      ]
    ]
  },
  "references-count": 36,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2001,
          8,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "BF1703132"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.bmt.1703132",
  "relation": {},
  "ISSN": [
    "0268-3369",
    "1476-5365"
  ],
  "subject": [],
  "container-title-short": "Bone Marrow Transplant",
  "published": {
    "date-parts": [
      [
        2001,
        8,
        1
      ]
    ]
  },
  "assertion": [
    {
      "value": "23 August 1999",
      "order": 1,
      "name": "received",
      "label": "Received",
      "group": {
        "name": "ArticleHistory",
        "label": "Article History"
      }
    },
    {
      "value": "11 May 2001",
      "order": 2,
      "name": "accepted",
      "label": "Accepted",
      "group": {
        "name": "ArticleHistory",
        "label": "Article History"
      }
    },
    {
      "value": "4 September 2001",
      "order": 3,
      "name": "first_online",
      "label": "First Online",
      "group": {
        "name": "ArticleHistory",
        "label": "Article History"
      }
    }
  ]
}